Recent News

• 05.08.2025 - Organogenesis Holdings Inc. First Quarter of Fiscal Year 2025 Earnings Conference Call
• 05.08.2025 - Organogenesis Holdings Inc. First Quarter of Fiscal Year 2025 Earnings Conference Call
• 05.08.2025 - Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results
• 05.08.2025 - Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results
• 05.08.2025 - Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results
• 04.11.2025 - Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
• 04.11.2025 - Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
• 04.11.2025 - Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
• 04.07.2025 - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
• 04.07.2025 - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Recent Filings

• 05.08.2025 - 8-K Current report
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.29.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.29.2025 - PRE 14A Other preliminary proxy statements
• 03.27.2025 - 8-K Current report
• 03.27.2025 - EX-99.1 EX-99.1
• 03.17.2025 - 144 Report of proposed sale of securities
• 03.12.2025 - 4 Statement of changes in beneficial ownership of securities